1. Neurotransmitter alteration in a testosterone propionate-induced polycystic ovarian syndrome rat model
   Nirja K. Chaudhari et al, 2017, Hormone Molecular Biology and Clinical Investigation CrossRef
2. A REVIEW OF PHARMACOLOGICAL SCREENING METHODS FOR EXPERIMENTALLY INDUCED POLYCYSTIC OVARIAN DISEASE (PCOD)
   Ramesh Selvaraj et al, 2021, INDIAN DRUGS CrossRef
3. Challenges in Establishing a Relevant Model of Polycystic Ovary Syndrome in Rats – A Mini Review
   Rakic Dejana et al, 2021, Serbian Journal of Experimental and Clinical Research CrossRef
4. Composition of Royal Jelly (RJ) and Its Anti-Androgenic Effect on Reproductive Parameters in a Polycystic Ovarian Syndrome (PCOS) Animal Model
   Norhamidar Ab Hamid et al, 2020, Antioxidants CrossRef
5. Cardiovascular Properties of the Androgen-Induced PCOS Model in Rats: The Role of Oxidative Stress
   Jovana Joksimovic Jovic et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
6. Resveratrol and Dulaglutide ameliorate adiposity and liver dysfunction in rats with diet-induced metabolic syndrome: Role of SIRT-1 / adipokines / PPARγ and IGF-1
   Hanan Abdel Moneam A. Shamardl et al, 2023, DARU Journal of Pharmaceutical Sciences CrossRef
7. Genetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary Syndrome
   Isabel Huang-Doran et al, 2016, Frontiers in Endocrinology CrossRef
8. Suppression of neurotransmission on gonadotropin-releasing hormone neurons in letrozole-induced polycystic ovary syndrome: A mouse model
   Pravin Bhattarai et al, 2023, Frontiers in Endocrinology CrossRef
9. Association between sex steroid hormones and subsequent hyperglycemia during pregnancy
   Ying Meng et al, 2023, Frontiers in Endocrinology CrossRef